InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Stanton Matthew, Directeur Scientifique. Director active across 1 company, notably Generation Bio Co.. Cumulatively, 19 disclosures have been published. Activity tracked since 10 May 2021. The latest transaction was disclosed on 14 September 2021 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Stanton Matthew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
1,674 sharesCommon StockSEC:0001415889-24-025338:0
1,674 sharesCommon StockSEC:0001415889-24-019646:0
1,674 sharesCommon StockSEC:0001415889-24-011043:0
7,437 sharesCommon StockSEC:0001415889-24-001333:0
7,437 sharesCommon StockSEC:0001415889-23-014361:0
7,437 sharesCommon StockSEC:0001415889-23-011237:0
7,437 sharesCommon StockSEC:0001415889-23-006609:0
7,438 sharesCommon StockSEC:0001415889-23-001087:0
7,438 sharesCommon StockSEC:0001415889-22-010646:0
14,876 sharesCommon StockSEC:0001415889-22-007759:0
4,500 shares@ US$4.5919.3% of flowCommon StockSEC:0001415889-21-004413:0
3,000 shares@ US$4.5912.8% of flowCommon StockSEC:0001415889-21-004381:0
1,500 shares@ US$4.596.5% of flowCommon StockSEC:0001415889-21-004091:0
1,500 shares@ US$4.596.5% of flowCommon StockSEC:0001415889-21-003853:0
3,000 shares@ US$4.5912.8% of flowCommon StockSEC:0001415889-21-003603:0
1,500 shares@ US$4.596.3% of flowCommon StockSEC:0001415889-21-003065:0
6,000 shares@ US$4.5924.9% of flowCommon StockSEC:0001415889-21-002954:0
1,500 shares@ US$4.596.2% of flowCommon StockSEC:0001415889-21-002706:0
8,600 shares@ US$0.604.7% of flowCommon StockSEC:0001415889-21-002417:0
19 of 19 declarations
About Stanton Matthew
Stanton Matthew is Directeur Scientifique at Generation Bio Co. (XNAS), where his listed function is CHIEF SCIENTIFIC OFFICER. He has 19 filings in total, and among the filings tracked, the period runs from 2021-05-12 to 2024-10-17, with the main transaction nature listed as Levée d'options.
